在帕金森氏症和阿尔茨海默氏症疾病中的肠道微生物群和免疫系统动态
Natasa Kustrimovic1, Sahar Balkhi2, Giorgia Bilato2,3
1Department of Biotechnology and Life Sciences, University of Insubria, 21100 Varese, Italy.
International journal of molecular sciences
|November 27, 2024
概括
肠道失调,肠道微生物的失衡,有助于神经退行性疾病中出现的神经炎症. 准肠道微生物群可能为阿尔茨海默氏症和帕金森病等疾病提供新的治疗方法.
科学领域:
- 微生物学 微生物学
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 肠道微生物群对于代谢,免疫和认知健康至关重要.
- 肠道失调与神经退行性疾病 (NDs) 相关,如帕金森病和阿尔茨海默病.
- 神经炎症,涉及微质细胞和免疫细胞,是NDs的一个关键特征.
研究的目的:
- 审查肠道失调症对神经炎症的影响.
- 探索微质细胞和免疫细胞在这个过程中的作用.
- 讨论针对NDs的肠道微生物群的治疗策略.
主要方法:
- 关于肠道微生物群,失生症和神经炎症的研究的文献综述.
- 对链接肠道微生物代谢物和免疫细胞激活机制的分析.
- 检查针对肠道微生物组的治疗干预措施.
主要成果:
- 肠道疾病可以通过微生物代谢物和免疫细胞调节加剧神经炎症.
- 微细胞和外围免疫细胞是受肠道微生物变化影响的关键参与者.
- 特定的微生物干预在临床前模型中显示出潜力.
结论:
- 肠道功能失调是与神经退行性疾病相关的神经炎症的一个重要因素.
- 调节肠道微生物群是一个有希望的治疗途径,用于管理NDs.
- 需要进一步的研究来将这些发现转化为临床实践.
相关概念视频
Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
Alzheimer's Disease: Overview
448
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
448


